Affluent Medical SA (FR:AFME) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Affluent Medical SA, a French medical technology company, is set to participate in several key scientific conferences in Q4 2024, aiming to showcase their innovative implantable medical devices for heart diseases and urinary incontinence. The company has reported progress in its medical devices, including a partnership with Edward Lifesciences and promising clinical trial results. With the goal of commercial launch by 2025/early 2026, Affluent Medical is advancing towards pivotal studies and approvals in their mission to improve patient care.
For further insights into FR:AFME stock, check out TipRanks’ Stock Analysis page.